Atoltivimab, Maftivimab, And Odesivimab 61434-0052
Product NDC
61434-0052- Manufacturer
- Catalent Indiana, Llc
- Dosage Form
- Injection, Solution
- Product Type
- Human Prescription Drug
- Marketing Start
- October 14, 2020
- Listing Expires
- December 31, 2026
Need to source Atoltivimab, Maftivimab, And Odesivimab? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Atoltivimab-Ebgn | 483.3 mg/14.5mL |
| Maftivimab-Ebgn | 483.3 mg/14.5mL |
| Odesivimab-Ebgn | 483.3 mg/14.5mL |
Packaging Options(1)
189 VIAL in 1 CASE (61434-052-00) / 14.5 mL in 1 VIAL